Studyhigh evidence
The Cost-Effectiveness of Enoxaparin Compared with Aspirin for Thromboprophylaxis in Patients with Orthopaedic Trauma.
The Journal of bone and joint surgery. American volume·May 6, 2026·PMID 41587264
Why it mattersRecent evidence shows aspirin is clinically comparable to enoxaparin for preventing death and pulmonary embolism in orthopaedic trauma. This analysis adds an economic dimension, suggesting aspirin is substantially more cost-effective, which could influence guideline recommendations and prescribing practices.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled